BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Citryll Presents Positive Data from Phase I Study of CIT-013 in Rheumatoid Arthritis at ACR Convergence 2025

  October 27, 2025

   · 

  4 min read
• Press Releases

  Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

  October 27, 2025

   · 

  3 min read
• Press Releases

  Health Canada Grants Authorization for “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease

  October 27, 2025

   · 

  13 min read
• Press Releases

  Innovent’s Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3

  October 27, 2025

   · 

  9 min read
• Press Releases

  Jupiter Endovascular Announces Positive Results From SPIRARE I First-in-human Study Presented at TCT 2025

  October 27, 2025

   · 

  4 min read
• Press Releases

  Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025

  October 27, 2025

   · 

  6 min read
• Press Releases

  New Data at American College of Gastroenterology Annual Meeting Show TissueCypher® Provides Actionable Risk Insights that Influence Clinical Management and Prompt Risk-Aligned Intervention in Barrett’s Esophagus

  October 27, 2025

   · 

  8 min read
• Press Releases

  Cristcot to Present Data on Novel Ulcerative Colitis Treatment at the American College of Gastroenterology 2025 Annual Meeting

  October 27, 2025

   · 

  9 min read
• Press Releases

  Cordis Unveiled Breakthrough Results from SELUTION DeNovo and SELUTION4ISR Randomized Trials at TCT 2025, Transforming Coronary Artery Disease (CAD) Treatment Beyond Stenting

  October 27, 2025

   · 

  4 min read
• Press Releases

  Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions

  October 27, 2025

   · 

  4 min read